Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10 CNS 3 Tumor-Agnostic 2 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Breast 1

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Cisplatin 631 Radiotherapy 339 pembrolizumab 329 Cetuximab 284 Docetaxel 226 Radiotherapy, Intensity-Modulated 221 Fluorouracil 199 Carboplatin 198 Paclitaxel 161 Nivolumab 145 Gemcitabine 125 Magnetic Resonance Spectroscopy 99 Radiation 91 Drug Therapy 86 Capecitabine 77 toripalimab 75 Surveys and Questionnaires 73 Surgical Procedures, Operative 72 Biopsy 62 durvalumab 61 Chemoradiotherapy 52 Blood Specimen Collection 52 Cyclophosphamide 50 Specimen Handling 47 camrelizumab 46 Radiosurgery 46 Erlotinib Hydrochloride 46 Standard of Care 44 130-nm albumin-bound paclitaxel 44 tislelizumab 42

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

LY-2157299 × Head & Neck × Clear all

NCT04605562 2021-09-05

Umbrella Biomarker-Guided Therapy in NPC

Sun Yat-sen University

Phase 2 Not yet recruiting

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡